|Articles|March 9, 2020
MYCAP CCX®: Cell Expansion of the Future
Author(s)Sartorius
-The MYCAP CCX system removes the need to perform transfers in a biosafety cabinet -Reduces the risk of contamination by eliminating significant nonaseptic procedures
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
